The Tokyo Guidelines (TG) provide evidence based criteria for the diagnosis and severity grading of acute cholecystitis and acute cholangitis. First published in 2007, there have been two revisions, the latest just published in 2018 (TG18). The guidelines are available in an app for smartphones, and the app is very useful in the ER and on the ward. Furthermore, standardization of criteria for diagnosis and severity grading provide a stable platform for performance of comparative outcome studies.1,2 Tables 67-1, 67-2, 67-3, 67-4 are Tokyo guidelines 2018 diagnostic criteria and severity grading for acute cholangitis and acute cholecystitis respectively.
A. Local signs of inflammation. (1) Murphy’s sign, (2) RUQ mass/pain/tenderness |
B. Systemic signs of inflammation, etc. (1) fever, (2) elevated CRP, (3) elevated WBC count |
C. Imaging findings Imaging findings characteristic of acute cholecystitis |
Suspected diagnosis: One item in A + one item in B Definite diagnosis: One item in A + one item in B + C |
Grade III (Severe) acute cholecystitis “Grade III” acute cholecystitis is associated with dysfunction of any one of the following organs/systems
|
Grade II (moderate) acute cholecystitis “Grade II” acute cholecystitis is associated with any one of the following conditions.
|
Grade I (mild) acute cholecystitis “Grade I” acute cholecystitis that does not meet the criteria of “Grade III” or “Grade II” acute cholecystitis. It can also be defined as acute cholecystitis in a healthy patient with no organ dysfunction and mild inflammatory changes in the gallbladder, making cholecystectomy a safe and low-risk operative procedure. |
| |||
| |||
Note:
| |||
Threshholds: | |||
A-1 | Fever | BT > 38°C | |
A-2 | Evidence of inflammatory response | WBC (× 1000/µL) | < 4, or > 10 |
CRP (mg/dL) | ≧ 1 | ||
B-1 | Jaundice | T-Bil ≧ 2 (mg/dL) | |
B-2 | Abnormal liver function tests | ALP (IU) | > 1.5 × STD |
γ GTP (IU) | > 1.5 × STD | ||
AST (IU) | > 1.5 × STD | ||
ALT (IU) | > 1.5 × STD |